Antimicrobial composition containing an oxidoreductase and an enhancer of the N-hydroxyanilide-type
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-038/44
C12N-009/02
C12N-009/04
C12N-009/06
C12N-009/08
출원번호
US-0437106
(1999-11-09)
우선권정보
DK-1998 01441 (1998-11-09)
발명자
/ 주소
Johansen, Charlotte
Deussen, Heinz-Josef
출원인 / 주소
Novozymes A/S
대리인 / 주소
Lambiris, Elias J.
인용정보
피인용 횟수 :
0인용 특허 :
10
초록▼
The present invention relates to an enzymatic composition capable of killing or inhibiting microbial cells or micro-organisms, e.g. in laundry, on hard surfaces, in water systems, on skin, on teeth or on mucous membranes. The present invention also relates to the use of said enzymatic composition fo
The present invention relates to an enzymatic composition capable of killing or inhibiting microbial cells or micro-organisms, e.g. in laundry, on hard surfaces, in water systems, on skin, on teeth or on mucous membranes. The present invention also relates to the use of said enzymatic composition for preserving food products, cosmetics, paints, coatings, etc.
대표청구항▼
The present invention relates to an enzymatic composition capable of killing or inhibiting microbial cells or micro-organisms, e.g. in laundry, on hard surfaces, in water systems, on skin, on teeth or on mucous membranes. The present invention also relates to the use of said enzymatic composition fo
The present invention relates to an enzymatic composition capable of killing or inhibiting microbial cells or micro-organisms, e.g. in laundry, on hard surfaces, in water systems, on skin, on teeth or on mucous membranes. The present invention also relates to the use of said enzymatic composition for preserving food products, cosmetics, paints, coatings, etc. ent is adjusted so as to allow the solid polymer particles to swell up to 500 percent after hydration. 13. A physiologically acceptable composition as set forth in claim 10 wherein the hydrophilic component is selected from the group consisting of poly(ethylene oxide), polyvinyl pyrrolidone, polyvinyl alcohol, poly(propylene oxide), poly(ethylene glycol), poly(propylene glycol), polytetramethylene oxide, polyacrylamide, poly(hydroxy ethyl acrylate), poly(hydroxy ethyl methacrylate), hydroxy ethyl cellulose, hydroxy propyl cellulose, methoxylated pectin gels, agar, starches, modified starches, alginates and hydroxy ethyl carbohydrate and the non-hydrophilic component is selected from the group consisting of silicones, polyether polyurethanes, polyester polyurethanes, ethylene copolymers, polyamides and aliphatic polyesters. 14. A physiologically acceptable composition as set forth in claim 1 wherein the solid polymer particles further comprises a radiopaque material. 15. A physiologically acceptable composition as set forth in claim 14 wherein the solid polymer particles have a particle size of greater than 25 microns. 16. A physiologically acceptable composition as set forth in claim 14 wherein the radiopaque material is selected from the group consisting of barium sulfate, bismuth subcarbonate, tantalum, tungsten, silver and mixtures thereof. 17. A physiologically acceptable composition as set forth in claim 1 wherein the liquid carrier is selected from the group consisting of glycerine, glycerol monoacetate, glycerol diacetate, polyethylene glycol, diethylene glycol, polyethylene glycol/polypropylene glycol block copolymers, low molecular weight polyethylene oxides, polysorbate and mixtures of the above. 18. A physiologically acceptable composition as set forth in claim 1 wherein the liquid carrier is nonaqueous. 19. A physiologically acceptable composition as set forth in claim 18 wherein the plurality of solid polymer particles is present in a selected concentration such that it hydrates and swells to the predetermined volume as the liquid carrier dissipates, to provide a final volume which is substantially equal to the selected volume. 20. A physiologically acceptable composition as set forth in claim 18 wherein the solid polymer particles comprise a hydrophilic component. 21. A physiologically acceptable composition as set forth in claim 20 wherein the solid polymer particles have a particle size sufficient to resist migration from a site of insertion into a patient's body. 22. A physiologically acceptable composition as set forth in claim 20 wherein the hydrophilic component swells up to 1,000 percent after hydration. 23. A physiologically acceptable composition as set forth in claim 20 wherein the hydrophilic component is selected from the group consisting of poly(ethylene oxide), polyvinyl pyrrolidone, polyvinyl alcohol, poly(propylene oxide), poly(ethylene glycol), poly(propylene glycol), polytetramethylene oxide, polyacrylamide, poly(hydroxy ethyl acrylate), poly(hydroxy ethyl methacrylate), hydroxy ethyl cellulose, hydroxy propyl cellulose, methoxylated pectin gels, agar, starches, modified starches, alginates and hydroxy ethyl carbohydrate. 24. A physiologically acceptable composition as set forth in claim 18 wherein the solid polymer particles comprise a non-hydrophilic component. 25. A physiologically acceptable composition as set forth in claim 24 wherein the solid polymer particles have a particle size sufficient to resist migration from a site of insertion into a patient's body. 26. A physiologically acceptable composition as set forth in claim 24 wherein the non-hydrophilic component is selected from the group consisting of silicones, polyether polyurethanes, polyester polyurethanes, ethylene copolymers, polyamides and aliphatic polyesters. 27. A physiologically acceptable composition as set forth in claim 18 wherein the solid polymer particles comprises a non-hydrophilic component and a hydrophilic componen
※ AI-Helper는 부적절한 답변을 할 수 있습니다.